Global Upstream Bioprocessing 麻豆原创 Research Report 2024

Publication ID:

PB505248972

Publication Date:

May 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The upstream process is defined as the entire process from early cell isolation and cultivation, to cell banking and culture expansion of the cells until final harvest (termination of the culture and collection of the live cell batch).
The global Upstream Bioprocessing market was valued at US$ 6701.8 million in 2023 and is anticipated to reach US$ 13800 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
North American market for Upstream Bioprocessing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Upstream Bioprocessing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Upstream Bioprocessing in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Upstream Bioprocessing include Danaher, Eppendorf, GE Healthcare, Parker Hannifin and Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Upstream Bioprocessing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Upstream Bioprocessing.
Report Scope
The Upstream Bioprocessing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Upstream Bioprocessing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Upstream Bioprocessing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Danaher
Eppendorf
GE Healthcare
Parker Hannifin
Thermo Fisher Scientific
Segment by Type
Bioreactors
Bioprocess Containers
Tubing and Connectors
Mixing Systems
Sensors and Probes
Segment by Application
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Upstream Bioprocessing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Upstream Bioprocessing 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bioreactors
1.2.3 Bioprocess Containers
1.2.4 Tubing and Connectors
1.2.5 Mixing Systems
1.2.6 Sensors and Probes
1.3 麻豆原创 by Application
1.3.1 Global Upstream Bioprocessing 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Upstream Bioprocessing 麻豆原创 Perspective (2019-2030)
2.2 Upstream Bioprocessing Growth Trends by Region
2.2.1 Global Upstream Bioprocessing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Upstream Bioprocessing Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Upstream Bioprocessing Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Upstream Bioprocessing 麻豆原创 Dynamics
2.3.1 Upstream Bioprocessing Industry Trends
2.3.2 Upstream Bioprocessing 麻豆原创 Drivers
2.3.3 Upstream Bioprocessing 麻豆原创 Challenges
2.3.4 Upstream Bioprocessing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Upstream Bioprocessing Players by Revenue
3.1.1 Global Top Upstream Bioprocessing Players by Revenue (2019-2024)
3.1.2 Global Upstream Bioprocessing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Upstream Bioprocessing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Upstream Bioprocessing Revenue
3.4 Global Upstream Bioprocessing 麻豆原创 Concentration Ratio
3.4.1 Global Upstream Bioprocessing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Upstream Bioprocessing Revenue in 2023
3.5 Upstream Bioprocessing Key Players Head office and Area Served
3.6 Key Players Upstream Bioprocessing Product Solution and Service
3.7 Date of Enter into Upstream Bioprocessing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Upstream Bioprocessing Breakdown Data by Type
4.1 Global Upstream Bioprocessing Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Upstream Bioprocessing Forecasted 麻豆原创 Size by Type (2025-2030)
5 Upstream Bioprocessing Breakdown Data by Application
5.1 Global Upstream Bioprocessing Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Upstream Bioprocessing Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Upstream Bioprocessing 麻豆原创 Size (2019-2030)
6.2 North America Upstream Bioprocessing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Upstream Bioprocessing 麻豆原创 Size by Country (2019-2024)
6.4 North America Upstream Bioprocessing 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Upstream Bioprocessing 麻豆原创 Size (2019-2030)
7.2 Europe Upstream Bioprocessing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Upstream Bioprocessing 麻豆原创 Size by Country (2019-2024)
7.4 Europe Upstream Bioprocessing 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Upstream Bioprocessing 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Upstream Bioprocessing 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Upstream Bioprocessing 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Upstream Bioprocessing 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Upstream Bioprocessing 麻豆原创 Size (2019-2030)
9.2 Latin America Upstream Bioprocessing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Upstream Bioprocessing 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Upstream Bioprocessing 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Upstream Bioprocessing 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Upstream Bioprocessing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Upstream Bioprocessing 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Upstream Bioprocessing 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Detail
11.1.2 Danaher Business Overview
11.1.3 Danaher Upstream Bioprocessing Introduction
11.1.4 Danaher Revenue in Upstream Bioprocessing Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Eppendorf
11.2.1 Eppendorf Company Detail
11.2.2 Eppendorf Business Overview
11.2.3 Eppendorf Upstream Bioprocessing Introduction
11.2.4 Eppendorf Revenue in Upstream Bioprocessing Business (2019-2024)
11.2.5 Eppendorf Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Upstream Bioprocessing Introduction
11.3.4 GE Healthcare Revenue in Upstream Bioprocessing Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 Parker Hannifin
11.4.1 Parker Hannifin Company Detail
11.4.2 Parker Hannifin Business Overview
11.4.3 Parker Hannifin Upstream Bioprocessing Introduction
11.4.4 Parker Hannifin Revenue in Upstream Bioprocessing Business (2019-2024)
11.4.5 Parker Hannifin Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Upstream Bioprocessing Introduction
11.5.4 Thermo Fisher Scientific Revenue in Upstream Bioprocessing Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Danaher
Eppendorf
GE Healthcare
Parker Hannifin
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.